Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2)

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 4, 1999, Pages 330-334

  Zapȩcka Dubno, Bozena ^a   Czyzyk, Artur ^a   Dworak, Anna ^a   Ba̧k, Marianna I ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

CAS 10238 21 8; CAS 657 24 9; Diabetes mellitus, non insulin dependent; Glibenclamide, clinical studies, effect on plasma amylin level; Metformin, clinical studies, effect on plasma amylin level

Indexed keywords

BIGUANIDE; GLIBENCLAMIDE; GLUCAGON; HEMOGLOBIN A1C; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INSULIN RESISTANCE; LACTIC ACIDOSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT CONTRAINDICATION;

EID: 0032895011     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300423     Document Type: Article

References (20)

1. [1] Opie, E. L., J. Exp. Med. 5, 397 (1900)
2. [2] Westermark, P., Wernstedt, C., Wilander, E. et al., Biochem. Biophys. Res. Commun. 140, 827 (1986)
3. [3] Cooper, G. J. S., Willis, A. C., Clark, A. et al., Proc. Natl. Acad. Sci. USA 84, 8628 (1987)
4. [4] DeFronzo, R. A., Bonadonna, R. C., Ferrannini, E., Diabetes Care 15, 318 (1992)
5. [5] Leighton, B., Cooper, G. J. S., Nature 335, 632 (1988)
6. [6] Molina, J. M., Cooper, G. J. S., Leighton, B. et al., Diabetes 39, 260 (1990)
7. [7] Frontoni, S., Choi, S. B., Banduch, D. et al., Diabetes 40, 568 (1991)
8. [8] WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646. WHO, Geneva (1980)
9. [9] Sanke, T., Hanabusa, T., Nakano, Y. et al., Diabetologia 34, 129 (1991)
10. [10] Ludvik, B., Lell, B., Hartter, E. et al., Diabetes 40, 1615 (1991)
11. [11] Ludvik, B., Berzlanovich, A., Hartter, E. et al., Nephrol. Dial. Transplant. 8, 694 A (1990)
12. [12] Kautzky-Willer, A., Thomaseth, K., Pacini, G. et al., Diabetologia 37, 188 (1994)
13. [13] Hartter, E., Svoboda, T., Ludvik, B. et al., Diabetologia 34, 52 (1991)
14. [14] Moore, C. X., Cooper, G. J. S., Biochem. Biophys. Res. Commun. 179, 1 (1991)
15. [15] Rachman, J., Payne, M. J., Levy, J. C. et al., Diabetes Care 21, 810 (1998)
16. [16] Kolterman, O. G., Gottlieb, A., Moyses, C. et al., Diabetes Care 18, 1179 (1995)
17. [17] Förster, H., Mehnert, H., Arzneim.-Forsch./Drug Res. 15, 1340 (1965)
18. [18] Czyzyk, A., Ławecki, J., Sadowski, J. et al., Diabetes 17, 492 (1968)
19. [19] Young, A., Pittner, R., Gedulin, B. et al., Biochem. Soc. Trans. 23, 325 (1995)
20. [20] Perrot, D., Claris, O., Guillaume, C. et al., Réanim. Soins Int. Méd. Urgence 2, 85 (1986)